MacroGenics (MGNX) PT Raised to $24 at BTIG, 'Discussions with Physicians Increase our Confidence in Vobra Duo’s Profile'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to MacroGenics (MGNX) PT Raised to $24 at BTIG, 'Discussions with Physicians Increase our Confidence in Vobra Duo’s Profile'

MacroGenics to Participate in Upcoming Investor Conferences

March 1, 2024 5:48 PM EST

ROCKVILLE, MD, March 01, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conferences in March 2024:

TD Cowens 44th Annual Health Care Conference (Boston). MacroGenics President & Chief Executive Officer, Scott Koenig, M.D., Ph.D., will participate in a Prostate Cancer Corporate Panel... More